Die KI- und Branchenexpertise von Cognizant in Kombination mit der generativen KI-Plattform NVIDIA BioNeMo bildet eine solide Grundlage zur Verbesserung der Ergebnisse im Gesundheitswesen und in den Biowissenschaften TEANECK, N.J., 19. März 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH)…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.